7/28/2021  3:51:22 PM Chg. -0.3400 Volume Bid7:26:44 PM Ask7:26:44 PM Market Capitalization Dividend Y. P/E Ratio
153.1600EUR -0.22% 426
Turnover: 65,698.2400
-Bid Size: - -Ask Size: - 67.33 bill.EUR 0.75% 807.26

Business description

EssilorLuxottica is a global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. Formed in 2018, its mission is to help people around the world to see more, be more and live life to its fullest by addressing their evolving vision needs and personal style aspirations. The company brings together the complementary expertise of two industry pioneers, one in advanced lens technology and the other in the craftsmanship of iconic eyewear, to set new industry standards for vision care and the consumer experience around it. Influential eyewear brands including Ray-Ban and Oakley, lens technology brands including Varilux® and Transitions®, and world-class retail brands including Sunglass Hut and LensCrafters are part of the EssilorLuxottica family.

Management board & Supervisory board

Paul Du Saillant
Management board
David Wielemans, Arnaud Ribadeau Dumas, Bernhard Nuesser, Chrystel Barranger, Éric Léonard, Éric Thoreux, Ernesto Diaz, Frédéric Mathieu, Grita Loebsack, Norbert Gorny, Rick Gadd
Supervisory board
Leonardo Del Vecchio, Annette Messemer, Cristina Scocchia, Delphine Zablocki, Francesco Milleri, Gianni Mion, Giovanni Giallombardo, Hubert Sagnières, Jeanette Wong, Juliette Favre, Léonel Ascencao Pereira, Lucia Morselli, Olivier Pécoux, Paul du Saillant, Romolo Bardin, Sabrina Pucci

Company data

Name: EssilorLuxottica SA
Address: 147, rue de Paris,F-94220 Charenton-le-Pont
Phone: +33-1-49-77-4224
Fax: -
E-mail: contact@essilor-luxottica.com
Internet: https://www.essilorluxottica.com/
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 12/31
Free Float: 63.50%
IPO date: -

Investor relations

Name: -
IR phone: +33-1-49-77-4216
IR Fax: -
IR e-mail: ir@essilor-luxottica.com

Company calendar

CW 31 | 7/30/2021 Interim Report 2nd Quarter/6 Months

Main Shareholders

Delfin S.A.R.L.